Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
This study investigates the photocatalytic degradation of amoxicillin (AMO) by simulated solar irradiation using WO3 as a catalyst. A three-factor-three-level Box-Behnken design (BBD) consisting of 30 experimental runs is employed with three independent variables: initial AMO concentration, catalyst dosage, and pH. The experimental results are analyzed in terms of AMO degradation and mineralization, the latter of which is measured using dissolved organic carbon (DOC). The results show that the photocatalytic degradation of AMO follows pseudo-first-order kinetics. AMO degradation efficiency and the pseudo-first-order rate constants decrease with increasing initial AMO concentration and pH and increase with increasing catalyst dosage. Though AMO degradation is almost fully complete under the experimental conditions, DOC removal is much lower; the highest DOC removal rate is 35.82% after 180 min. Using these experimental results, second-order polynomial response surface models for AMO and DOC removal are constructed. In the AMO removal model, the first-order terms are the most significant contributors to the prediction, followed by the quadratic and interaction terms. Initial AMO concentration and pH have a significant negative impact on the photocatalytic degradation of AMO, while catalyst dosage has a significant positive impact. In contrast, in the DOC removal model, the quadratic terms make the most significant contribution to the prediction and the first-order terms the least. The optimal conditions for the photocatalytic degradation of AMO are found to be an initial AMO concentration of 1.0 μM, a catalyst dosage of 0.104 g/L, and a pH of 4, under which almost complete removal of AMO is achieved (99.99%).
Pubmed ID: 31249354
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
American chemical, life science and biotechnology company owned by Merck KGaA. Merger of Sigma Chemical Company and Aldrich Chemical Company. Provides organic and inorganic chemicals, building blocks, reagents, advanced materials and stable isotopes for chemical synthesis, medicinal chemistry and materials science, antibiotics, buffers, carbohydrates, enzymes, forensic tools, hematology and histology, nucleotides, proteins, peptides, amino acids and their derivatives.
View all literature mentionsA statistical software package that allows the user to import data, create graphs, and perform statistical analysis. It can perform basic statistical tests like descriptive statistics, hypothesis tests, confidence intervals, and normality tests as well as regression and ANOVA and quality assessment.
View all literature mentions